Pregled bibliografske jedinice broj: 889770
The Outcome of Breast Augmentation using Local Infiltration Anesthesia (LIA)
The Outcome of Breast Augmentation using Local Infiltration Anesthesia (LIA) // Abstracts and Highlight Papers of the 35th Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) Congress 2016 ; u: Regional anesthesia and pain medicine 41 (2016) (S) e1-e162
XX, XXX, 2016. str. e157-e158 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 889770 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Outcome of Breast Augmentation using Local Infiltration Anesthesia (LIA)
Autori
Bagatin, Dinko ; Šakić, Kata ; Bagatin, Tomica ; Šakić, Livija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts and Highlight Papers of the 35th Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) Congress 2016 ; u: Regional anesthesia and pain medicine 41 (2016) (S) e1-e162
/ - , 2016, E157-e158
Skup
Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) Congress (35 ; 2016)
Mjesto i datum
XX, XXX, 2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
breast ; augmentation ; local infiltration ; anaesthesia
Sažetak
Local infiltration anesthesia (LIA) technique to obtain regional anesthesia and vasoconstriction of the skin and subcutaneous tissues is routinely adopted for primary subglandular breast augmentation. This series evaluates advantages and disadvantages of LIA in elective augmentation breast surgery as well as patients' response to this procedure. 60 patients underwent bilateral primary breast augmentation under preoperative LIA, combinations of 5 ml 0.5% levobupivacaine and 4 ml 2% lidocaine with epinephrine on each side and compared to only Ketolorac groups respectively. Midazolam 0.05 mg/kg IV were given as premedication. Surgery was performed under sevoflurane anesthesia. Postoperative pain was assessed by visual analogue scale(VAS) treating with Ketolorac and Tramadol. 60 patients were included in the LIA and only Ketorolac groups respectively. Postoperative pain was lower at 2 and 4 hour after surgery in theLIA group. Recovery room time 1 to 2 in 76, 6% vs 4-6 in Ketorolac group of patients. Vomiting were found in aaveraged 125 minutes. VAS in LIA group weretotal of 9 (5.3%) patients without complications such as hematoma or seroma formation. 86, 7% of patients discharge same day. Single shot infiltration with levobupivacaine improves postoperative pain control after breast surgery. Perioperative physicians should consider delivering LIA earlier during the procedure as opposed to solely at the time of wound closure.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Scopus
- MEDLINE